Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Karikó, Katalin, Muramatsu, Hiromi, Welsh, Frank A, Ludwig, János, Kato, Hiroki, Akira, Shizuo, Weissman, Drew·2008·Molecular Therapy

Cited by (1,003)

Items 101–200 of 1,003

  1. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
    István Tombácz, Dorottya I. Laczko, Hamna Shahnawaz, Hiromi Muramatsu, Ambika Natesan, Amir Yadegari, Tyler Ellis Papp, Mohamad‐Gabriel Alameh, Vladimir V. Shuvaev, Barbara L. Mui et al. · 2021 · Molecular Therapy
  2. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
    Danny Wilbie, Johanna Walther, Enrico Mastrobattista · 2019 · Accounts of Chemical Research
  3. A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair
    Kang Sun, Yi‐yuan Li, Jin Jin · 2021 · Signal Transduction and Targeted Therapy
  4. Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
    Stadler, Christiane R, Bähr-Mahmud, Hayat, Celik, Leyla, Hebich, Bernhard, Roth, Alexandra S, Roth, René P, Karikó, Katalin, Türeci, Özlem, Sahin, Ugur · 2017 · Nature Medicine
  5. Synthesis and Biological Evaluation of Ionizable Lipid Materials for the In Vivo Delivery of Messenger RNA to B Lymphocytes
    Owen S. Fenton, Kevin J. Kauffman, James C. Kaczmarek, Rebecca Lane McClellan, Siddharth Jhunjhunwala, Mark W. Tibbitt, Manhao D. Zeng, Eric Andrew Appel, J. Robert Dorkin, Faryal F. Mir et al. · 2017 · Advanced Materials
  6. Role of nanotechnology behind the success of mRNA vaccines for COVID-19
    Amit Khurana, Prince Allawadhi, Isha Khurana, Sachin Allwadhi, Ralf Weiskirchen, Anil Kumar Banothu, Deepak Chhabra, Kamaldeep Joshi, Kala Kumar Bharani · 2021 · Nano Today
  7. Regulation and functions of non-m6A mRNA modifications
    Hanxiao Sun, Kai Li, Cong Liu, Chengqi Yi · 2023 · Nature Reviews Molecular Cell Biology
  8. Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin
    Karikó, Katalin, Muramatsu, Hiromi, Keller, Jason M, Weissman, Drew · 2012 · Molecular Therapy
  9. Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
    Pardi, Norbert, Parkhouse, Kaela, Kirkpatrick, Ericka, McMahon, Meagan, Zost, Seth J., Mui, Barbara L., Tam, Ying K., Karikó, Katalin, Barbosa, Christopher J., Madden, Thomas D. et al. · 2018 · Nature Communications
  10. A User’s Guide to Cell-Free Protein Synthesis
    Nicole E. Gregorio, Max Z. Levine, Javin P. Oza · 2019 · Methods and Protocols
  11. SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
    Emily Bettini, Michela Locci · 2021 · Vaccines
  12. RNA pseudouridylation: new insights into an old modification
    Junhui Ge, Yi‐Tao Yu · 2013 · Trends in Biochemical Sciences
  13. The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines
    Pedro Morais, Hironori Adachi, Yi‐Tao Yu · 2021 · Frontiers in Cell and Developmental Biology
  14. Principles for designing an optimal mRNA lipid nanoparticle vaccine
    Kon, Edo, Elia, Uri, Peer, Dan · 2022 · Current Opinion in Biotechnology
  15. Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
    Yi Song, Jian Li, Yuzhang Wu · 2024 · Signal Transduction and Targeted Therapy
  16. Lipid Nanoparticle–mRNA Formulations for Therapeutic Applications
    Chang Wang, Yuebao Zhang, Yizhou Dong · 2021 · Accounts of Chemical Research
  17. Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification
    Vaidyanathan, Sriram, Azizian, Krist T., Haque, A.K.M. Ashiqul, Henderson, Jordana M., Hendel, Ayal, Shore, Sabrina, Antony, Justin S., Hogrefe, Richard I., Kormann, Michael S.D., Porteus, Matthew H. et al. · 2018 · Molecular Therapy Nucleic Acids
  18. Next‐Generation Vaccines: Nanoparticle‐Mediated DNA and mRNA Delivery
    Ho, William, Gao, Mingzhu, Li, Fengqiao, Li, Zhongyu, Zhang, Xue‐Qing, Xu, Xiaoyang · 2021 · Advanced Healthcare Materials
  19. mRNA Vaccines in the COVID-19 Pandemic and Beyond
    Michael J. Hogan, Norbert Pardi · 2021 · Annual Review of Medicine
  20. Controlling timing and location in vaccines
    Darrell J. Irvine, Aereas Aung, Murillo Silva · 2020 · Advanced Drug Delivery Reviews
  21. Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
    Majed Ghattas, Garima Dwivedi, Marc Lavertu, Mohamad‐Gabriel Alameh · 2021 · Vaccines
  22. Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation
    Hanhan Shi, Peiwei Chai, Renbing Jia, Xianqun Fan · 2020 · Molecular Cancer
  23. Lipid nanoparticles in the development of mRNA vaccines for COVID-19
    Barnabas Wilson, K.M. Geetha · 2022 · Journal of Drug Delivery Science and Technology
  24. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
    Xuexiang Han, Mohamad‐Gabriel Alameh, Kamila Butowska, James J. Knox, Kendall A. Lundgreen, Majed Ghattas, Ningqiang Gong, Lulu Xue, Ying Xu, Marc Lavertu et al. · 2023 · Nature Nanotechnology
  25. Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution
    Qing Dai, Lisheng Zhang, Hui‐Lung Sun, Kinga Pajdzik, Lei Yang, Cheng‐Wei Ju, Cheng‐Wei Ju, Shun Liu, Yuru Wang, Linda Zhang et al. · 2022 · Nature Biotechnology
  26. mRNA vaccines in disease prevention and treatment
    Gang Zhang, Tianyu Tang, Yinfeng Chen, Xing Huang, Tingbo Liang · 2023 · Signal Transduction and Targeted Therapy
  27. Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
    Zhang, Lizhou, More, Kunal R., Ojha, Amrita, Jackson, Cody B., Quinlan, Brian D., Li, Hao, He, Wenhui, Farzan, Michael, Pardi, Norbert, Choe, Hyeryun · 2023 · npj Vaccines
  28. Regulation and Function of RNA Pseudouridylation in Human Cells
    Erin K. Borchardt, Nicole M. Martínez, Wendy V. Gilbert · 2020 · Annual Review of Genetics
  29. Mechanism of action of mRNA-based vaccines
    Iavarone, Carlo, O’hagan, Derek T., Yu, Dong, Delahaye, Nicolas F., Ulmer, Jeffrey B. · 2017 · Expert Review of Vaccines
  30. mRNA vaccines for infectious diseases — advances, challenges and opportunities
    Norbert Pardi, Florian Krammer · 2024 · Nature Reviews Drug Discovery
  31. PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
    Parhiz, Hamideh, Shuvaev, Vladimir V., Pardi, Norbert, Khoshnejad, Makan, Kiseleva, Raisa Yu, Brenner, Jacob S., Uhler, Thomas, Tuyishime, Steven, Mui, Barbara L., Tam, Ying K. et al. · 2018 · Journal of Controlled Release
  32. An RNA toolbox for cancer immunotherapy
    Pastor, Fernando, Berraondo, Pedro, Etxeberria, Iñaki, Frederick, Josh, Sahin, Ugur, Gilboa, Eli, Melero, Ignacio · 2018 · Nature Reviews Drug Discovery
  33. Pseudouridinylation of mRNA coding sequences alters translation
    Daniel E. Eyler, Monika K. Franco, Zahra Batool, Monica Z. Wu, Michelle L. Dubuke, Malgorzata Dobosz-Bartoszek, Joshua D. Jones, Yury S. Polikanov, Bijoyita Roy, Kristin S. Koutmou · 2019 · Proceedings of the National Academy of Sciences
  34. mRNA transcript therapy
    Weissman, Drew · 2015 · Expert Review of Vaccines
  35. Vaccines for COVID-19
    John S. Tregoning, E S Brown, Hannah M. Cheeseman, Katie E. Flight, Sophie L. Higham, N-M Lemm, Benjamin F. Pierce, David C. Stirling, Ziyin Wang, Katrina M. Pollock · 2020 · Clinical & Experimental Immunology
  36. Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
    Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, Alicia Rodríguez‐Gascón, Maria Ángelés Solinís, Ana del Pozo‐Rodríguez · 2020 · Nanomaterials
  37. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening
    Pedro Pires Goulart Guimarães, Rui Zhang, Roman Spektor, Mingchee Tan, Amanda Chung, Margaret M. Billingsley, Rakan D. El-Mayta, Rachel Riley, Lili Wang, James M. Wilson et al. · 2019 · Journal of Controlled Release
  38. Reprogramming human fibroblasts to pluripotency using modified mRNA
    P. Mandal, Derrick J. Rossi · 2013 · Nature Protocols
  39. RNA-Based Vaccines in Cancer Immunotherapy
    Megan Ann McNamara, Smita K. Nair, Eda K. Holl · 2015 · Journal of Immunology Research
  40. Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models
    Christian Hotz, Timothy R. Wagenaar, Friederike Gieseke, Dinesh S. Bangari, Michelle Callahan, Hui Cao, Jan Diekmann, Mustafa Diken, Christian R. Grunwitz, Andy Hebert et al. · 2021 · Science Translational Medicine
  41. Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice
    Mohammad Ariful Islam, Rice Jamie, Emma Reesor, Harshal R. Zope, Wei Tao, Michael Lim, Jianxun Ding, Yunhan Chen, Dike Aduluso, Bruce R. Zetter et al. · 2020 · Biomaterials
  42. Engineering cytokine therapeutics
    Jeroen Deckers, Tom Anbergen, Ayla M. Hokke, Anne de Dreu, David P. Schrijver, Koen de Bruin, Yohana C. Toner, Thijs J. Beldman, Jamie B. Spangler, Tom F. A. de Greef et al. · 2023 · Nature Reviews Bioengineering
  43. Formulation and Delivery Technologies for mRNA Vaccines
    Chunxi Zeng, Chengxiang Zhang, Patrick G. Walker, Yizhou Dong · 2020 · Current topics in microbiology and immunology
  44. mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation
    Oren Levy, Weian Zhao, Luke J. Mortensen, Sarah LeBlanc, Kyle Tsang, Moyu Fu, Joseph A. Phillips, Vinay Sagar, Priya N. Anandakumaran, Jessica Ngai et al. · 2013 · Blood
  45. Pseudouridine: Still mysterious, but never a fake (uridine)!
    Felix Spenkuch, Yuri Motorin, Mark Helm · 2014 · RNA Biology
  46. Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine
    Kwon, Hyokyoung, Kim, Minjeong, Seo, Yunmi, Moon, Yae Seul, Lee, Hwa Jeong, Lee, Kyuri, Lee, Hyukjin · 2018 · Biomaterials
  47. N6-methyl-adenosine modification in messenger and long non-coding RNA
    Tao Pan · 2013 · Trends in Biochemical Sciences
  48. In Vitro Transcription of Long RNA Containing Modified Nucleosides
    Norbert Pardi, Hiromi Muramatsu, Drew Weissman, Katalin Karikó · 2012 · Methods in molecular biology
  49. How mRNA therapeutics are entering the monoclonal antibody field
    Van Hoecke, Lien, Roose, Kenny · 2019 · Journal of Translational Medicine
  50. Chemical and structural effects of base modifications in messenger RNA
    Emily M. Harcourt, Anna M. Kietrys, Eric T. Kool · 2017 · Nature
  51. Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines
    Xia, Xuhua · 2021 · Vaccines
  52. Biomaterials for vaccine-based cancer immunotherapy
    Rui Zhang, Margaret M. Billingsley, Michael J. Mitchell · 2018 · Journal of Controlled Release
  53. Tapping the RNA world for therapeutics
    Judy Lieberman · 2018 · Nature Structural & Molecular Biology
  54. Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo
    Kevin J. Kauffman, Faryal F. Mir, Siddharth Jhunjhunwala, James C. Kaczmarek, Juan E. Hurtado, Jung H. Yang, Matthew J. Webber, Piotr S. Kowalski, Michael W. Heartlein, Frank DeRosa et al. · 2016 · Biomaterials
  55. Pseudouridine: the fifth RNA nucleotide with renewed interests
    Xiaoyu Li, Shiqing Ma, Chengqi Yi · 2016 · Current Opinion in Chemical Biology
  56. Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
    Chen Xue, Qingfei Chu, Qiuxian Zheng, Shiman Jiang, Zhengyi Bao, Yuanshuai Su, Juan Lü, Lanjuan Li · 2022 · Signal Transduction and Targeted Therapy
  57. RNA: The new revolution in nucleic acid vaccines
    Andrew J. Geall, Christian W. Mandl, Jeffrey B. Ulmer · 2013 · Seminars in Immunology
  58. Nucleic acid drugs: recent progress and future perspectives
    Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, Jialiang Hu, Hanmei Xu · 2024 · Signal Transduction and Targeted Therapy
  59. Clinical and immunological effects of mRNA vaccines in malignant diseases
    Annkristin Heine, Stefan Juranek, Peter Brossart · 2021 · Molecular Cancer
  60. Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine
    Leif G. Carlsson, Jonathan C. Clarke, Christopher Yu Tai Yen, Francine M. Gregoire, Tamsin Albery, Martin A. Billger, Ann‐Charlotte Egnell, Li‐Ming Gan, Karin Jennbacken, Edvin Johansson et al. · 2018 · Molecular Therapy — Methods & Clinical Development
  61. A Comprehensive Review of Small Interfering RNAs (siRNAs): Mechanism, Therapeutic Targets, and Delivery Strategies for Cancer Therapy
    Jiaying Zhang, Bo Chen, Chunyuan Gan, Hongyan Sun, Jiaxin Zhang, Lin Feng · 2023 · International Journal of Nanomedicine
  62. HPLC purification of in vitro transcribed long RNA
    Weissman, Drew, Pardi, Norbert, Muramatsu, Hiro, Karikó, Katalin · 2013 · Methods in molecular biology
  63. Delivery strategies of cancer immunotherapy: recent advances and future perspectives
    Zhongwei Zhao, Liyun Zheng, Weiqian Chen, Wei Weng, Jingjing Song, Jiansong Ji · 2019 · Journal of Hematology & Oncology
  64. mRNA-Based Protein Replacement Therapy for the Heart
    Magadum, Ajit, Kaur, Keerat, Zangi, Lior · 2019 · Molecular Therapy
  65. Detection technologies for RNA modifications
    Yan Zhang, Liang Lu, Xiaoyu Li · 2022 · Experimental & Molecular Medicine
  66. mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
    Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, Ming-Hsiang Hong, Joyce Pei‐Yi Yuan, Jui-Ling Tsai, Han‐Chung Wu · 2023 · Journal of Biomedical Science
  67. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
    Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos, Peter Andrew McCullough · 2022 · Food and Chemical Toxicology
  68. Non-liver mRNA Delivery
    Loughrey, David, Dahlman, James E. · 2022 · Accounts of Chemical Research
  69. RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
    Wei-Wei Liu, Si-Qing Zheng, Li Tian, Yun-Fei Fei, Chen Wang, Shuang Zhang, Fei Wang, Guanmin Jiang, Hao Wang · 2024 · Signal Transduction and Targeted Therapy
  70. High-throughput and high-content bioassay enables tuning of polyester nanoparticles for cellular uptake, endosomal escape, and systemic in vivo delivery of mRNA
    Yuan Rui, David R. Wilson, Stephany Yi Tzeng, Hannah M. Yamagata, Deepti Sudhakar, Marranne Conge, Cynthia A. Berlinicke, Donald J. Zack, Anthony D. Tuesca, Jordan J. Green · 2022 · Science Advances
  71. Recent Advancement in mRNA Vaccine Development and Applications
    Nojoud AL Fayez, Majed Saeed Nassar, Abdullah Awad Alshehri, Meshal K. Alnefaie, Fahad A. Almughem, Bayan Y. Alshehri, Abdullah O. Alawad, Essam A. Tawfik · 2023 · Pharmaceutics
  72. Arginine‐Rich Peptide‐Based mRNA Nanocomplexes Efficiently Instigate Cytotoxic T Cell Immunity Dependent on the Amphipathic Organization of the Peptide
    Udhayakumar, Vimal K., De Beuckelaer, Ans, McCaffrey, Joanne, McCrudden, Cian M., Kirschman, Jonathan L., Vanover, Daryll, Van Hoecke, Lien, Roose, Kenny, Deswarte, Kim, De Geest, Bruno G. et al. · 2017 · Advanced Healthcare Materials
  73. Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm
    Wei Wang, Shuo Feng, Zhuyifan Ye, Hanlu Gao, Jinzhong Lin, Defang Ouyang · 2021 · Acta Pharmaceutica Sinica B
  74. Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines
    János Szebeni, Gert Storm, Julia Y. Ljubimova, Mariana Castells, Elizabeth Jane Phillips, Keren Turjeman, Yechezkel Barenholz, Daan J.A. Crommelin, Marina A. Dobrovolskaia · 2022 · Nature Nanotechnology
  75. Chemical Modifications to RNA: A New Layer of Gene Expression Regulation
    Jinghui Song, Chengqi Yi · 2017 · ACS Chemical Biology
  76. Nucleotide modifications within bacterial messenger RNAs regulate their translation and are able to rewire the genetic code
    Thomas Philipp Hoernes, Nina Clementi, Klaus Faserl, Heidelinde Glasner, Kathrin Breuker, Herbert H. Lindner, Alexander Hüttenhofer, Matthias David Erlacher · 2015 · Nucleic Acids Research
  77. Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA
    Bowen Li, Allen Yujie Jiang, Idris O. Raji, Caroline G. Atyeo, Theresa M. Raimondo, Akiva G. R. Gordon, Luke H. Rhym, Tahoura S. Samad, Corina MacIsaac, Jacob J. Witten et al. · 2023 · Nature Biomedical Engineering
  78. mRNA cancer vaccines: Advances, trends and challenges
    Qing He, Hua Gao, Dejiang Tan, Heng Zhang, Junzhi Wang · 2022 · Acta Pharmaceutica Sinica B
  79. Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format
    Kyle K.L. Phua, Kam W. Leong, Smita K. Nair · 2013 · Journal of Controlled Release
  80. The Past, Present, and Future of Non-Viral CAR T Cells
    Alex Moretti, Marianna Ponzo, Charles A. Nicolette, Irina Y. Tcherepanova, Andrea Biondi, Chiara Francesca Magnani · 2022 · Frontiers in Immunology
  81. Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across
    Minnaert, An-Katrien, Vanluchene, Helena, Verbeke, Rein, Lentacker, Ine, De Smedt, Stefaan C., Raemdonck, Koen, Sanders, Niek N., Remaut, Katrien · 2021 · Advanced Drug Delivery Reviews
  82. Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
    Fatima Rizvi, Elissa Everton, Anna R. Smith, Hua Liu, Elizabeth Osota, Mitchell B. Beattie, Ying K. Tam, Norbert Pardi, Drew Weissman, Valerie Gouon–Evans · 2021 · Nature Communications
  83. A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications
    Furong Qin, Fan Xia, Hongli Chen, Bomiao Cui, Yun Feng, Ping Zhang, Jiao Chen, Min Luo · 2021 · Frontiers in Cell and Developmental Biology
  84. Big Is Beautiful: Enhanced saRNA Delivery and Immunogenicity by a Higher Molecular Weight, Bioreducible, Cationic Polymer
    Blakney, Anna K., Zhu, Yunqing, McKay, Paul F., Bouton, Clément R., Yeow, Jonathan, Tang, Jiaqing, Hu, Kai, Samnuan, Karnyart, Grigsby, Christopher L., Shattock, Robin J. et al. · 2020 · ACS Nano
  85. Effects of Chemically Modified Messenger RNA on Protein Expression
    Bin Li, Xiao Ling Luo, Yizhou Dong · 2016 · Bioconjugate Chemistry
  86. Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans
    Cagigi, Alberto, Loré, Karin · 2021 · Vaccines
  87. Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics—An innate immune system standpoint
    Yasmin Granot-Matok, Dan Peer · 2017 · Seminars in Immunology
  88. Decoding pseudouridine: an emerging target for therapeutic development
    Jonas Cerneckis, Qi Cui, Chuan He, Chengqi Yi, Yanhong Shi · 2022 · Trends in Pharmacological Sciences
  89. Transcriptome-wide dynamics of RNA pseudouridylation
    John J. Karijolich, Chengqi Yi, Yi‐Tao Yu · 2015 · Nature Reviews Molecular Cell Biology
  90. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis
    Tsvetelina Veselinova Velikova, Tsvetoslav Georgiev · 2021 · Rheumatology International
  91. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
    Jamile Ramos da Silva, Karine Bitencourt Rodrigues, Guilherme Formoso Pelegrin, Natiely Silva Sales, Hiromi Muramatsu, Mariângela de Oliveira Silva, Bruna F.M.M. Porchia, Ana Carolina Ramos Moreno, Luana R. M. M. Aps, Aléxia Adrianne Venceslau-Carvalho et al. · 2023 · Science Translational Medicine
  92. Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial
    Vesa Anttila, Antti Saraste, Juhani M. Knuuti, Pekka A. Jaakkola, Marja Hedman, Sara Svedlund, Maria Lagerstrom Fermer, Magnus Kjaer, Anders Jeppsson, Li‐Ming Gan · 2020 · Molecular Therapy — Methods & Clinical Development
  93. In vivo chimeric antigen receptor (CAR)-T cell therapy
    Adrian Bot, Andrew M. Scharenberg, Kevin M. Friedman, Lin T. Guey, Robert Hofmeister, James I. Andorko, Michael Klichinsky, Frank Neumann, Jagesh V. Shah, Andrew J. Swayer et al. · 2025 · Nature Reviews Drug Discovery
  94. The identity and methylation status of the first transcribed nucleotide in eukaryotic mRNA 5’ cap modulates protein expression in living cells
    Sikorski, Pawel J, Warminski, Marcin, Kubacka, Dorota, Ratajczak, Tomasz, Nowis, Dominika, Kowalska, Joanna, Jemielity, Jacek · 2020 · Nucleic Acids Research
  95. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases
    Pai‐Chi Teng, Yanwen Liang, Aliaksandr A. Yarmishyn, Yu‐Jer Hsiao, Ting-Yi Lin, Tzu-Wei Lin, Yuan‐Chi Teng, Yi-Ping Yang, Mong‐Lien Wang, Chian‐Shiu Chien et al. · 2021 · International Journal of Molecular Sciences
  96. Non-viral delivery of the CRISPR/Cas system: DNA versus RNA versus RNP
    Yi Lin, Ernst Wagner, Ulrich Lächelt · 2022 · Biomaterials Science
  97. mRNA in the Context of Protein Replacement Therapy
    Theofanis Vavilis, Εleni Stamoula, Alexandra Ainatzoglou, Athanasios Sachinidis, Malamatenia Lamprinou, Ioannis Dardalas, Ioannis S. Vizirianakis · 2023 · Pharmaceutics
  98. Nanomedicine-Based Approaches for mRNA Delivery
    Uchida, Satoshi, Perche, Federico, Pichon, Chantal, Cabral, Horacio · 2020 · Molecular Pharmaceutics
  99. Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety
    Van der Jeught, Kevin, De Koker, Stefaan, Bialkowski, Lukasz, Heirman, Carlo, Tjok Joe, Patrick, Perche, Federico, Maenhout, Sarah, Bevers, Sanne, Broos, Katrijn, Deswarte, Kim et al. · 2018 · ACS Nano
  100. In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency
    Mahiny, Azita J, Dewerth, Alexander, Mays, Lauren E, Alkhaled, Mohammed, Mothes, Benedikt, Malaeksefat, Emad, Loretz, Brigitta, Rottenberger, Jennifer, Brosch, Darina M, Reautschnig, Philipp et al. · 2015 · Nature Biotechnology